Gender specific eRNA TBX5-AS1 as the immunological biomarker for male patients with lung squamous cell carcinoma in pan-cancer screening
As an innate feature of human beings, gender differences have an influence on various biological phenotypes, yet it does not attract enough attention in genomics studies. The prognosis of multiple carcinomas usually exhibits a favorable ending for female patients, but the neglect of gender differenc...
Guardado en:
Autores principales: | Tao Yan, Kai Wang, Qidi Zhao, Junjie Zhuang, Hongchang Shen, Guoyuan Ma, Lei Cong, Jiajun Du |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
PeerJ Inc.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f0cdc809e27244219b1c2dca14e88eb2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Role of afatinib in the treatment of advanced lung squamous cell carcinoma
por: Vavalà T
Publicado: (2017) -
Identification of factors related to immunotherapy efficacy and prognosis in patients with advanced head and neck squamous cell carcinoma
por: Xuanli Xu, et al.
Publicado: (2021) -
Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of Dickkopf-1 (DKK1)
por: Shuang Gao, et al.
Publicado: (2021) -
Pan-Cancer Analysis Reveals the Signature of TMC Family of Genes as a Promising Biomarker for Prognosis and Immunotherapeutic Response
por: Jing Song, et al.
Publicado: (2021) -
PPP1R14B Is a Prognostic and Immunological Biomarker in Pan-Cancer
por: Mingxia Deng, et al.
Publicado: (2021)